Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hoth Therapeutics completes phase 1 of in-life dose escalation study for treating Eczema
Image: Hoth Therapeutics completes phase 1 of in-life dose escalation study for treating Eczema. Photo: courtesy of Philippe Delavie from Pixabay.
Image: Hoth Therapeutics completes phase 1 of in-life dose escalation study for treating Eczema. Photo: courtesy of Philippe Delavie from Pixabay.